Search Results - "DE VANE, C. L"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain by Meyer, E M, Potter, L T, De Vane, C L, Irwin, I, MacKay, S L, Miller, R, Ruttenber, A J

    “…Benzoyltropine and tropacocaine are two contaminants of street-cocaine reported to have parasympatholytic activity. Because the mechanism underlying this…”
    Get more information
    Journal Article
  2. 2

    Clinical implications of antidepressant pharmacokinetics and pharmacogenetics by Cohen, L J, De Vane, C L

    Published in The Annals of pharmacotherapy (01-12-1996)
    “…To review available data on pharmacokinetic and pharmacogenetic influences on the response to antidepressant therapy, analyze the mechanisms for and clinical…”
    Get more information
    Journal Article
  3. 3

    The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein by Wang, Jun-Sheng, Ruan, Ying, Taylor, Robin M., Donovan, Jennifer L., Markowitz, John S., DeVane, C. Lindsay

    “…P-glycoprotein (P-gp) in the brain capillary endothelial cell limits the entry of many drugs into the brain. Our previous in-vitro study using ATPase as a…”
    Get full text
    Journal Article
  4. 4

    Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors by DeVane, C L

    Published in Cellular and molecular neurobiology (01-08-1999)
    “…1. Five drugs with the predominant pharmacologic effect of inhibiting the neuronal reuptake of serotonin are available worldwide for clinical use. This class…”
    Get full text
    Journal Article
  5. 5

    Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment by Halaris, Angelos, Zhu, He, Ali, Jeffery, Nasrallah, Amelia, Lindsay De Vane, C., Piletz, John E.

    “…An elevation of I1 (imidazoline-1)-binding sites on platelets may be a state marker for depression. Herein, platelet I1 sites were compared in two groups of…”
    Get full text
    Journal Article
  6. 6

    Clinical significance of drug binding, protein binding, and binding displacement drug interactions by DeVane, C Lindsay

    Published in Psychopharmacology bulletin (2002)
    “…Drugs widely used in clinical psychopharmacology, with few exceptions, are hepatically eliminated and circulate in the blood bound to plasma proteins. Often,…”
    Get more information
    Journal Article
  7. 7

    Bupropion in depression. II. The role of metabolites in clinical outcome by Golden, R N, De Vane, C L, Laizure, S C, Rudorfer, M V, Sherer, M A, Potter, W Z

    Published in Archives of general psychiatry (01-02-1988)
    “…We studied the steady-state pharmacokinetics of bupropion hydrochloride, a unicyclic aminoketone antidepressant, in depressed patients. The metabolites…”
    Get more information
    Journal Article
  8. 8

    Prescribing attitudes of different physician groups regarding fluoxetine by Levin, G M, DeVane, C L

    Published in The Annals of pharmacotherapy (01-12-1993)
    “…To determine the attitudes and prescribing patterns of family medicine and psychiatric physicians regarding fluoxetine. A three-part questionnaire was…”
    Get more information
    Journal Article
  9. 9

    The analysis and disposition of imipramine and its active metabolites in man by SUTFIN, T. A, DE VANE, C. L, JUSKO, W. J

    Published in Psychopharmacologia (01-01-1984)
    “…Single oral and intramuscular (i.m.) doses of imipramine (IMI) were administered to four normal males. Serum and urine concentrations of IMI, desipramine (DMI)…”
    Get full text
    Journal Article
  10. 10

    Cimetidine interaction with amitriptyline by CURRY, S. H, DE VANE, C. L, WOLFE, M. M

    Published in European journal of clinical pharmacology (01-01-1985)
    “…The interaction of cimetidine with amitriptyline was assessed by means of amitriptyline and nortriptyline plasma concentration measurements, standing blood…”
    Get full text
    Journal Article